Literature DB >> 18282763

Elevated serum levels of IL-1ra in children with Plasmodium falciparum malaria are associated with increased severity of disease.

Chandy C John1, Gregory S Park, Nadia Sam-Agudu, Robert O Opoka, Michael J Boivin.   

Abstract

Animal models suggest that cytokines and chemokines play a role in cerebral malaria (CM) pathogenesis, but levels of a number of cytokines and chemokines thought to be important in the pathogenesis of other infectious diseases are not well characterized in children with CM. Serum levels of granulocyte-colony stimulating factor (G-CSF), interleukin-1 receptor antagonist (IL-1ra), interleukin-8 (IL-8) and monocyte chemoattractant protein-1 (MCP-1) were measured in 77 children with CM, 70 children with uncomplicated malaria (UM) and 63 healthy community children (CC) in Uganda. Children with CM had elevated serum levels of IL-1ra and IL-8 as compared to children with UM (median levels in pg/ml, 11,891 vs. 6510, P=0.05, and 63 vs. 41, P=0.01, respectively). Children with CM who died (n=4) had higher serum levels than survivors of IL-1ra (median levels in pg/ml, 65,757 vs. 10,355, P=0.02), G-CSF (709 vs. 117, P=0.02), and MCP-1 (1275 vs. 216, P=0.03) but not IL-8 (76 vs. 62, P=NS). Elevated IL-1ra levels are associated with increased disease severity in children with malaria, and very elevated levels of IL-1ra, G-CSF and MCP-1 are seen in children who die of CM.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18282763      PMCID: PMC2323512          DOI: 10.1016/j.cyto.2007.12.008

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  17 in total

1.  A predominantly anti-inflammatory cytokine profile is associated with disease severity in meningococcal sepsis.

Authors:  Enitan D Carrol; Alistair P J Thomson; Ashley P Jones; Graham Jeffers; C Anthony Hart
Journal:  Intensive Care Med       Date:  2005-08-27       Impact factor: 17.440

2.  Granulocyte colony-stimulating factor inhibits neutrophil apoptosis at the local site after severe head and thoracic injury.

Authors:  W Ertel; M Keel; U Buergi; T Hartung; H G Imhof; O Trentz
Journal:  J Trauma       Date:  1999-05

3.  Chemokine patterns in meningococcal disease.

Authors:  Anne-Sophie W Møller; Anna Bjerre; Berit Brusletto; Gun Britt Joø; Petter Brandtzaeg; Peter Kierulf
Journal:  J Infect Dis       Date:  2005-01-18       Impact factor: 5.226

4.  The pattern of interleukin-1beta (IL-1beta) and its modulating agents IL-1 receptor antagonist and IL-1 soluble receptor type II in acute meningococcal infections.

Authors:  M van Deuren; J van der Ven-Jongekrijg; E Vannier; R van Dalen; G Pesman; A K Bartelink; C A Dinarello; J W van der Meer
Journal:  Blood       Date:  1997-08-01       Impact factor: 22.113

Review 5.  Chemokines and chemotaxis of leukocytes in infectious meningitis.

Authors:  F Lahrtz; L Piali; K S Spanaus; J Seebach; A Fontana
Journal:  J Neuroimmunol       Date:  1998-05-01       Impact factor: 3.478

6.  Increased concentrations of interleukin-6 and interleukin-1 receptor antagonist and decreased concentrations of beta-2-glycoprotein I in Gambian children with cerebral malaria.

Authors:  P H Jakobsen; V McKay; S D Morris-Jones; W McGuire; M B van Hensbroek; S Meisner; K Bendtzen; I Schousboe; I C Bygbjerg; B M Greenwood
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

7.  Transient elevation of granulocyte colony-stimulating factor levels in cerebrospinal fluid at the initial stage of aseptic meningitis in children.

Authors:  K Fukushima; A Ishiguro; T Shimbo
Journal:  Pediatr Res       Date:  1995-02       Impact factor: 3.756

8.  A functional polymorphism in the IL1B gene promoter, IL1B -31C>T, is not associated with cerebral malaria in Thailand.

Authors:  Jun Ohashi; Izumi Naka; Akihiro Doi; Jintana Patarapotikul; Hathairad Hananantachai; Noppadon Tangpukdee; Sornchai Looareesuwan; Katsushi Tokunaga
Journal:  Malar J       Date:  2005-08-14       Impact factor: 2.979

9.  CC and CXC chemokine levels in children with meningococcal sepsis accurately predict mortality and disease severity.

Authors:  Clementien L Vermont; Jan A Hazelzet; Ester D de Kleijn; Germie P J M van den Dobbelsteen; Ronald de Groot
Journal:  Crit Care       Date:  2006-02       Impact factor: 9.097

10.  Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages.

Authors:  H Bouharoun-Tayoun; C Oeuvray; F Lunel; P Druilhe
Journal:  J Exp Med       Date:  1995-08-01       Impact factor: 14.307

View more
  25 in total

Review 1.  Diagnosis and management of the neurological complications of falciparum malaria.

Authors:  Saroj K Mishra; Charles R J C Newton
Journal:  Nat Rev Neurol       Date:  2009-04       Impact factor: 42.937

2.  Whole-Blood Transcriptional Signatures Composed of Erythropoietic and NRF2-Regulated Genes Differ Between Cerebral Malaria and Severe Malarial Anemia.

Authors:  Srinivas Nallandhighal; Gregory S Park; Yen-Yi Ho; Robert O Opoka; Chandy C John; Tuan M Tran
Journal:  J Infect Dis       Date:  2019-01-01       Impact factor: 5.226

Review 3.  Adjunctive therapy for cerebral malaria and other severe forms of Plasmodium falciparum malaria.

Authors:  Chandy C John; Elizabeth Kutamba; Keith Mugarura; Robert O Opoka
Journal:  Expert Rev Anti Infect Ther       Date:  2010-09       Impact factor: 5.091

4.  Involvement of inflammatory chemokines in survival of human monocytes fed with malarial pigment.

Authors:  Giuliana Giribaldi; Mauro Prato; Daniela Ulliers; Valentina Gallo; Evelin Schwarzer; Oskar B Akide-Ndunge; Elena Valente; Silvia Saviozzi; Raffaele A Calogero; Paolo Arese
Journal:  Infect Immun       Date:  2010-08-23       Impact factor: 3.441

5.  Identification of inflammatory biomarkers for pediatric malarial anemia severity using novel statistical methods.

Authors:  John M Ong'echa; Gregory C Davenport; John M Vulule; James B Hittner; Douglas J Perkins
Journal:  Infect Immun       Date:  2011-08-22       Impact factor: 3.441

6.  Developmental outcomes in Malawian children with retinopathy-positive cerebral malaria.

Authors:  Michael J Boivin; Melissa J Gladstone; Maclean Vokhiwa; Gretchen L Birbeck; Jed G Magen; Connie Page; Margaret Semrud-Clikeman; Felix Kauye; Terrie E Taylor
Journal:  Trop Med Int Health       Date:  2010-12-08       Impact factor: 2.622

7.  Thrombocytopenia May Mediate Disease Severity in Plasmodium falciparum Malaria Through Reduced Transforming Growth Factor Beta-1 Regulation of Proinflammatory and Anti-inflammatory Cytokines.

Authors:  Benjamin R Hanisch; Paul Bangirana; Robert O Opoka; Gregory S Park; Chandy C John
Journal:  Pediatr Infect Dis J       Date:  2015-07       Impact factor: 2.129

8.  Acute brain MRI findings in 120 Malawian children with cerebral malaria: new insights into an ancient disease.

Authors:  M J Potchen; S D Kampondeni; K B Seydel; G L Birbeck; C A Hammond; W G Bradley; J K DeMarco; S J Glover; J O Ugorji; M T Latourette; J E Siebert; M E Molyneux; T E Taylor
Journal:  AJNR Am J Neuroradiol       Date:  2012-04-19       Impact factor: 3.825

9.  Polymorphic variability in the interleukin (IL)-1beta promoter conditions susceptibility to severe malarial anemia and functional changes in IL-1beta production.

Authors:  Collins Ouma; Gregory C Davenport; Gordon A Awandare; Christopher C Keller; Tom Were; Michael F Otieno; John M Vulule; Jeremy Martinson; John M Ong'echa; Robert E Ferrell; Douglas J Perkins
Journal:  J Infect Dis       Date:  2008-10-15       Impact factor: 5.226

10.  Plasma cytokine concentrations indicate that in vivo hormonal regulation of immunity is altered during long-duration spaceflight.

Authors:  Brian E Crucian; Sara R Zwart; Satish Mehta; Peter Uchakin; Heather D Quiriarte; Duane Pierson; Clarence F Sams; Scott M Smith
Journal:  J Interferon Cytokine Res       Date:  2014-04-04       Impact factor: 2.607

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.